24.03
Uniqure N V Borsa (QURE) Ultime notizie
uniQure N.V. Securities Fraud Class Action Result of FDA - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - GlobeNewswire Inc.
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - GlobeNewswire Inc.
QURE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages QURE Investors with Losses to Contact the Firm - Financial Times
QURE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Reminds uniQure Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026QURE - PR Newswire
Wolfe Research Initiates Coverage on uniQure (QURE) with 'Peer P - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
5 Analysts Assess uniQure: What You Need To Know - Benzinga
Holzer & Holzer, LLC Reminds QURE Investors of the April - GlobeNewswire
Shareholders that lost money on uniQure N.V.(QURE) Urged to - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Quarterly Risk: Can uniQure NV continue delivering strong returns - baoquankhu1.vn
uniQure to Announce 2025 Financial Results - The Manila Times
uniQure N.V. to Report Q4 and Full Year 2025 Financial Results on March 2, 2026 - Quiver Quantitative
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
UniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsQURE - marketscreener.com
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit – Company Announcement - Financial Times
QURE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
uniQure (NASDAQ:QURE) Stock Price Down 5.8% – Should You Sell? - Defense World
Will uniQure N.V. stock recover faster than marketPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
Avoro Capital Advisors LLC Increases Stake in uniQure NV - GuruFocus
RTW INVESTMENTS, LP Reduces Stake in uniQure NV - GuruFocus
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - PR Newswire
Should I average down on uniQure N.V. stockJuly 2025 Reactions & Weekly Top Stock Performers List - mfd.ru
Notice of Class Action Lawsuit Against uniQure N.V. - Intellectia AI
ROSEN, NATIONAL TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
uniQure (NASDAQ:QURE) Stock Price Down 5.8%Here's Why - MarketBeat
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler - GlobeNewswire
QURE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 – Company AnnouncementFT.com - Financial Times
Will uniQure N.V. stock go up in YEARMarket Risk Summary & Community Verified Watchlist Alerts - mfd.ru
uniQure N.V. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 13, 2026 to Discuss Your RightsQURE - Nasdaq
uniQure N.V. Securities Fraud Class Action Lawsuit Filed by Kessl - The National Law Review
uniQure Faces Securities Fraud Class Action After FDA Approval Delay - National Today
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
QURE SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire
Levi & Korsinsky Reminds uniQure Investors of the Pending - GlobeNewswire
uniQure Faces Securities Class Action Lawsuit - Intellectia AI
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure LawsuitQURE - PR Newswire
User - The Chronicle-Journal
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Avoiding Lag: Real-Time Signals in (QURE) Movement - Stock Traders Daily
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against uniQure N.V. - The Malaysian Reserve
02:09 ETQURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - Longbridge
uniQure (QURE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against uniQure N.V. – Company AnnouncementFT.com - Financial Times
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact The ... - Bluefield Daily Telegraph
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Why uniQure (QURE) Is Down 12.0% After AMT-130 Lawsuits Challenge Its FDA Milestone Story - simplywall.st
UNIQURE N.V. (QURE) DEADLINE ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline - ACCESS Newswire
uniQure investors face April 13 deadline for class action lawsuit By Investing.com - Investing.com India
uniQure (NASDAQ:QURE) Trading Up 6.6%Should You Buy? - MarketBeat
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE - ChartMill
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE - FinancialContent
Class Action Announcement for uniQure N.V. Investors: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. - NewMediaWire
Class Action Announcement for uniQure N.V. Investors: Kessler Top - The National Law Review
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):